Health Care & Life Sciences » Pharmaceuticals | Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. | Income Statement

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
22,204
23,487
23,579
23,189
23,927
49,713
Cost of Goods Sold (COGS) incl. D&A
14,975
15,423
15,136
15,743
15,129
38,350
Gross Income
7,229
8,064
8,443
7,446
8,797
11,363
SG&A Expense
5,806
6,477
6,730
6,038
6,683
8,489
EBIT
1,172
-
1,450
1,941
2,110
2,802
Unusual Expense
1
77
123
65
31
7
Non Operating Income/Expense
12
8
13
42
165
369
Interest Expense
59
52
54
29
12
284
Pretax Income
1,289
1,651
1,753
2,045
2,550
4,384
Income Tax
280
323
349
451
432
574
Equity in Affiliates
262
197
255
227
324
376
Consolidated Net Income
1,270
1,525
1,659
1,821
2,443
4,186
Net Income
1,237
1,503
1,604
1,762
2,377
4,076
Net Income After Extraordinaries
1,237
1,503
1,604
1,762
2,377
4,076
Net Income Available to Common
1,237
1,503
1,604
1,762
2,377
4,076
EPS (Basic)
0.97
1.16
1.24
1.26
1.46
2.51
Basic Shares Outstanding
1,276
1,291
1,291
1,403
1,626
1,626
EPS (Diluted)
0.97
1.16
1.24
1.26
1.46
2.51
Diluted Shares Outstanding
1,276
1,291
1,291
1,403
1,626
1,626
EBITDA
1,406
1,736
1,726
2,190
2,373
3,197
Other Operating Expense
251
106
263
533
5
71
Non-Operating Interest Income
22
57
87
157
318
1,439
Minority Interest Expense
34
22
55
59
66
110

About Guangzhou Baiyunshan Pharmaceutical Holdings Co.

View Profile
Address
No. 45 Sha Mian North Street
Guangzhou Guangdong 510130
China
Employees -
Website http://www.gpc.com.cn
Updated 07/08/2019
Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. engages in the manufacture, wholesale, retail, import, and export of pharmaceutical products, medical apparatus, and Chinese medicine. It operates in the following segments: Great Southern TCM, Great Commerce, and Great Health. The Great Southern TCM segment provides Chinese and Western medicine, chemicals for medicine, natural drugs, biological medicine.